ECHO Trial
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) study is a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using depot medroxyprogesterone acetate (DMPA), Levonorgestrel (LNG) implant and copper intrauterine devices (IUDs).
Countries
Active Dates
10/01/2014 to 12/31/2020
Faculty Involved
Health Topics